Home › Funds › Bridge City Capital, LLC › AMPH
Bridge City Capital, LLC position in AMPH
AMPHASTAR PHARMACEUTICALS IN · Health Care
Bridge City Capital, LLC reported holding 383,901 shares of AMPH (AMPHASTAR PHARMACEUTICALS IN) in its Q3 2026 13F filing — a position valued at US$9.9M, representing 2.07% of its reported portfolio and ranking #6 among its reported holdings. Bridge City Capital, LLC has disclosed AMPH holdings in 13 of the last 13 reported quarters, going back to Q3 2023.
Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR
How Bridge City Capital, LLC's AMPH position evolved
Bridge City Capital, LLC first disclosed a stake in AMPH in Q3 2023 at 22,659 shares (US$1.0M). The position peaked in Q3 2026 at 383,901 shares, worth US$9.9M. Across 13 filings, Bridge City Capital, LLC increased the stake 10 time(s), trimmed it 2 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 383,901 shares valued at US$9.9M — an increase of 45,193 shares quarter over quarter.. Notable position changes include a 52% increase in Q4 2023 (shares fell 29% over the following quarter), a 65% increase in Q1 2025 (shares fell 21% over the following quarter), a 73% increase in Q4 2025 (shares fell 27% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2023 | 22.66K | $1.04M | New |
| Q4 2023 | 34.50K | $2.13M | Add |
| Q1 2024 | 34.77K | $1.53M | Add |
| Q2 2024 | 48.95K | $1.96M | Add |
| Q3 2024 | 71.08K | $3.45M | Add |
| Q4 2024 | 70.09K | $2.60M | Reduce |
| Q1 2025 | 115.86K | $3.36M | Add |
| Q2 2025 | 138.64K | $3.18M | Add |
| Q3 2025 | 136.26K | $3.63M | Reduce |
| Q4 2025 | 235.49K | $6.31M | Add |
| Q1 2026 | 335.11K | $6.56M | Add |
| Q2 2026 | 338.71K | $6.84M | Add |
| Q3 2026 | 383.90K | $9.91M | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About AMPH and 13F data
AMPH (AMPHASTAR PHARMACEUTICALS IN) is a Health Care company. 18 other funds we track also report a position in AMPH — the largest reported positions include Context Capital Management, LLC (US$84.6M), DeepCurrents Investment Group LLC (US$41.0M), OAKTREE CAPITAL MANAGEMENT LP (US$37.2M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding AMPH
- Context Capital Management, LLC 90.32M sh · $84.60M · Q3 2026
- DeepCurrents Investment Group LLC 45.02M sh · $40.98M · Q2 2026
- OAKTREE CAPITAL MANAGEMENT LP 40.88M sh · $37.20M · Q2 2026
- Empyrean Capital Partners, LP 24.27M sh · $22.02M · Q2 2026
- Fort Baker Capital Management LP 12.50M sh · $11.42M · Q2 2026
More on Bridge City Capital, LLC
FAQ
How long has Bridge City Capital, LLC held AMPH?
Bridge City Capital, LLC has disclosed AMPH holdings in 13 of the last 13 reported quarters, going back to Q3 2023.
What is Bridge City Capital, LLC's current position in AMPH?
As of Q3 2026, Bridge City Capital, LLC holds 383.90K shares of AMPH (AMPHASTAR PHARMACEUTICALS IN), valued at $9.91M, representing 2.07% of its reported portfolio and ranking #6.
Has Bridge City Capital, LLC been buying or selling AMPH?
In the latest 13F filing (Q3 2026), Bridge City Capital, LLC increased its position in AMPH. The position peaked in Q3 2026 at 383.90K shares.
Which other funds hold AMPH?
Other major institutional holders of AMPH include Context Capital Management, LLC, DeepCurrents Investment Group LLC, OAKTREE CAPITAL MANAGEMENT LP, among 18 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.